Early use of gliflozin for older adults with heart failure
Part of Heart & circulation clinical trials.
This trial tests whether giving gliflozin (a type of diabetes pill also used for heart failure) early in the emergency department helps older patients who are admitted for worsening heart failure. It aims to see if it can improve recovery and reduce the need for intensive treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years or older.
- You are in the emergency department with worsening heart failure symptoms like shortness of breath, swelling, or weight gain.
- You have high levels of a heart stress marker (BNP or NT-proBNP) in your blood.
- You are expected to be admitted to the hospital.
- You have never taken gliflozin before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if dapagliflozin, a medication usually used for diabetes, can help people with acute heart failure recover heart function. If you are in the hospital for heart failure, this study will check if the drug improves how your heart squeezes.
This trial tests if dapagliflozin helps reduce fat around the heart in people with a type of heart failure where the heart pumps normally but is stiff. It might improve symptoms and overall health.
This study tests whether a medication called empagliflozin (a diabetes drug) can improve heart function in older adults with high blood pressure and obesity who are at risk for heart failure but do not have it yet. You would take the pill daily and have heart ultrasounds to check your heart's health.
This trial tests whether adding dapagliflozin (a medication that helps protect the heart and kidneys) helps people with heart failure who are also on peritoneal dialysis. It may offer extra support for your heart and kidney health.
This trial tests whether a diabetes drug called dapagliflozin (also used for heart failure) can help people recover better after a recent heart attack. It's for adults who are already on standard blood thinners and have had a heart attack in the past week.
This trial tests if dapagliflozin or acetazolamide works better for people hospitalized with heart failure who have extra fluid in their body (congestion). The study will compare how well each medication helps remove fluid when used with standard IV diuretics.
Hear when a new Acute Heart Failure (AHF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.